121 related articles for article (PubMed ID: 9335457)
1. Modulation of human stromelysin 3 promoter activity and gene expression by human breast cancer cells.
Ahmad A; Marshall JF; Basset P; Anglard P; Hart IR
Int J Cancer; 1997 Oct; 73(2):290-6. PubMed ID: 9335457
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional induction of stromelysin-3 in mesodermal cells is mediated by an upstream CCAAT/enhancer-binding protein element associated with a DNase I-hypersensitive site.
Luo D; Guérin E; Ludwig MG; Stoll I; Basset P; Anglard P
J Biol Chem; 1999 Dec; 274(52):37177-85. PubMed ID: 10601280
[TBL] [Abstract][Full Text] [Related]
3. Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review.
Basset P; Wolf C; Chambon P
Breast Cancer Res Treat; 1993; 24(3):185-93. PubMed ID: 8435474
[TBL] [Abstract][Full Text] [Related]
4. Stromelysin-3 expression by mammary tumor-associated fibroblasts under in vitro breast cancer cell induction.
Wang CS; Têtu B
Int J Cancer; 2002 Jun; 99(6):792-9. PubMed ID: 12115479
[TBL] [Abstract][Full Text] [Related]
5. Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression.
Wolf C; Rouyer N; Lutz Y; Adida C; Loriot M; Bellocq JP; Chambon P; Basset P
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1843-7. PubMed ID: 8446598
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of MMP-11 (stromelysin-3) expression in mouse fibroblasts by cytokines, collagen and co-culture with human breast cancer cell lines.
Selvey S; Haupt LM; Thompson EW; Matthaei KI; Irving MG; Griffiths LR
BMC Cancer; 2004 Jul; 4():40. PubMed ID: 15272933
[TBL] [Abstract][Full Text] [Related]
7. Stromelysin-3 in stromal tissue as a control factor in breast cancer behavior.
Basset P; Wolf C; Rouyer N; Bellocq JP; Rio MC; Chambon P
Cancer; 1994 Aug; 74(3 Suppl):1045-9. PubMed ID: 7518738
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
9. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy.
Masson R; Lefebvre O; Noël A; Fahime ME; Chenard MP; Wendling C; Kebers F; LeMeur M; Dierich A; Foidart JM; Basset P; Rio MC
J Cell Biol; 1998 Mar; 140(6):1535-41. PubMed ID: 9508784
[TBL] [Abstract][Full Text] [Related]
10. Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression.
Ahmad A; Hanby A; Dublin E; Poulsom R; Smith P; Barnes D; Rubens R; Anglard P; Hart I
Am J Pathol; 1998 Mar; 152(3):721-8. PubMed ID: 9502414
[TBL] [Abstract][Full Text] [Related]
11. Expression of stromelysin-3 and nm23 in breast carcinoma and related tissues.
Hähnel E; Dawkins H; Robbins P; Hähnel R
Int J Cancer; 1994 Jul; 58(2):157-60. PubMed ID: 8026874
[TBL] [Abstract][Full Text] [Related]
12. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
[TBL] [Abstract][Full Text] [Related]
13. Cellular localisation by in situ hybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activator RNAs in breast cancer.
Escot C; Zhao Y; Puech C; Rochefort H
Breast Cancer Res Treat; 1996; 38(2):217-26. PubMed ID: 8861840
[TBL] [Abstract][Full Text] [Related]
14. Identification of promoter activity and differential expression of transcripts encoding the murine stromelysin-1 gene in renal cells.
Yee J; Kuncio GS; Bhandari B; Shihab FS; Neilson EG
Kidney Int; 1997 Jul; 52(1):120-9. PubMed ID: 9211354
[TBL] [Abstract][Full Text] [Related]
15. Induction of collagenase and stromelysin gene expression by mechanical injury in a vascular smooth muscle-derived cell line.
James TW; Wagner R; White LA; Zwolak RM; Brinckerhoff CE
J Cell Physiol; 1993 Nov; 157(2):426-37. PubMed ID: 8227172
[TBL] [Abstract][Full Text] [Related]
16. Structure and promoter characterization of the human stromelysin-3 gene.
Anglard P; Melot T; Guérin E; Thomas G; Basset P
J Biol Chem; 1995 Sep; 270(35):20337-44. PubMed ID: 7657606
[TBL] [Abstract][Full Text] [Related]
17. Stromelysin-3 mRNA expression and malignancy: comparison with clinicopathological features and type IV collagenase mRNA expression in breast tumors.
Kawami H; Yoshida K; Ohsaki A; Kuroi K; Nishiyama M; Toge T
Anticancer Res; 1993; 13(6A):2319-23. PubMed ID: 8297152
[TBL] [Abstract][Full Text] [Related]
18. Alternative splicing and promoter usage generates an intracellular stromelysin 3 isoform directly translated as an active matrix metalloproteinase.
Luo D; Mari B; Stoll I; Anglard P
J Biol Chem; 2002 Jul; 277(28):25527-36. PubMed ID: 12006591
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
Udayakumar TS; Nagle RB; Bowden GT
Prostate; 2004 Jan; 58(1):66-75. PubMed ID: 14673954
[TBL] [Abstract][Full Text] [Related]
20. Characterization of monoclonal antibodies against stromelysin-3 and their use to evaluate stromelysin-3 levels in breast carcinoma by semi-quantitative immunohistochemistry.
Santavicca M; Noel A; Chenard MP; Lutz Y; Stoll I; Segain JP; Rouyer N; Rio MC; Wolf C; Belloco JP
Int J Cancer; 1995 Oct; 64(5):336-41. PubMed ID: 7591307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
